Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2008-06-13
2010-10-05
Goddard, Laura B (Department: 1642)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S193100, C514S002600, C530S327000, C530S328000
Reexamination Certificate
active
07807172
ABSTRACT:
The invention provides a method and reagents for determining the presence and/or amount of human thyroglobulin in a biological sample. In one embodiment, the method comprises (a) digesting a biological sample containing proteins to provide peptide fragments; (b) contacting the digested sample with a binding reagent comprising a plurality of antibodies that are capable of binding to at least one thyroglobulin peptide fragment; and (c) determining the presence and/or amount of the thyroglobulin peptide fragments that are bound to the binding reagent. In some embodiments, the binding reagent comprises a plurality of antibodies capable of binding to at least one thyroglobulin peptide fragment set forth in TABLE 1. In some embodiments, the binding regent comprises a plurality of antibodies capable of binding to at least one thyroglobulin peptide selected from the group consisting of SEQ ID NO:2, SEQ ID NO:3, and SEQ ID NO:5.
REFERENCES:
patent: 2004/0072251 (2004-04-01), Anderson
Saboori et al (Clinical Exp Immunology, 1994, 98:454-458).
Anderson, N.L., et al., “Mass Spectrometric Quantitation of Peptides and Proteins Using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA),” Journal of Proteome Research 3(2):235-244, 2004.
Barr, J.R., et al., “Isotope Dilution-Mass Spectrometric Quantification of Specific Proteins: Model Application With Apolipoprotein A-I,” Clinical Chemistry 42(10):1676-1682, 1996.
Bondar, O.P., et al., “LC-MS/MS Quantification of Zn-α2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer,” Clinical Chemistry 53(4):673-678, Apr. 2007.
Consiglio, E., et al., “Characterization of Phosphate Residues on Thyroglobulin,” Journal of Biological Chemistry 262(21):10304-10314, Jul. 1987.
Demers, L.M., and C.A. Spencer (eds.), “Thyroglobulin (Tg),” Laboratory Medicine Practice Guidelines, vol. 13, Laboratory Support for the Diagnosis of Thyroid Disease, National Academy of Clinical Biochemistry, Washington, D.C., 2002, pp. 55-65.
Ericsson, U.-B., et al., “A High Prevalence of Thyroglobulin Autoantibodies in Adults With and Without Thyroid Disease as Measured With a Sensitive Solid-Phase Immunosorbent Radioassay,” Clinical Immunology and Immunopathology 37(2):154-162, Nov. 1985.
Feldt-Rasmussen, “Human Thyroglobulin Reference Material (CRM 457). 2nd Part: Physicochemical Characterization and Certification,” Annales de Biologie Clinique 54(10-11):343-348, 1996.
Gentile, F., et al., “Identification of Hormonogenic Tyrosines in Fragment 1218-1591 of Bovine Thyroglobulin by Mass Spectrometry,” Journal of Biological Chemistry 272(1):639-646, Jan. 1997.
Hoofnagle, A., and M.H. Wener, “Serum Thyroglobulin: A Model of Immunoassay Imperfection,” Clinical Laboratory International 12(8):12-14, Dec. 2006.
Kloos, R.T., and E.L. Mazzaferri, “A Single Recombinant Human Thyrotropin-Stimulated Serum Thryoglobulin Measurement Predicts Differentiated Thyroid Carcinoma Metastases Three to Five Years Later,” Journal of Endocrinology & Metabolism 90(9):5047-5057, Sep. 2005.
Kuhn, E., et al., “Quantification of C-Reactive Protein in the Serum of Patients With Rheumatoid Arthritis Using Multiple Reaction Monitoring Mass Spectrometry and 13C-Labeled Peptide Standards,” Proteomics 4:1175-1186, 2004.
Okosieme, O.E., et al., “Thyroglobulin Antibodies in Serum of Patients With Differentiated Thyroid Cancer: Relationship Between Epitope Specificities and Thyroglobulin Recovery,” Clinical Chemistry 51(4):1-6, Feb. 2005.
Pacini, F., “Follow-Up of Differentiated Thyroid Cancer,” European Journal of Nuclear Medicine 29(Suppl. 2):S492-S496, Aug. 2002.
Preissner, C.M., et al., “Phantoms in the Assay Tube: Heterophile Antibody Interferences in Serum Thyroglobulin Assays,” Journal of Endocrinology & Metabolism 88(7):3069-3074, Jul. 2003.
Rifai, N., et al., “Protein Biomarker Discovery and Validation: The Long and Uncertain Path to Clinical Utility,” Nature Biotechnology 24(8):971-983, Aug. 2006.
Saghari, M., et al., “Efficacy of Radioiodine Therapy in the Treatment of Elevated Serum Thyroglobulin in Patients With Differentiated Thyroid Carcinoma and Negative Whole-Body Iodine Scan,” Nuclear Medicine Communications 27 (7):567-572, Jul. 2006.
Sapin, R., “Insulin Immunoassays: Fast Approaching 50 Years of Existence and Still Calling for Standardization,” Clinical Chemistry 53(5):810-812, 2007.
Selby, C., “Interference in Immunoassay,” Annals of Clinical Biochemistry 36(Pt 6):704-721, Nov. 1999.
Slev, P.R., “Performance Characteristics of Seven Automated CA 15-3 Assays,” American Journal of Clinical Pathology 125(5):752-757, 2006.
Spencer, C.A., “Challenges of Serum Thyroglobulin (Tg) Measurement in the Presence of Tg Autoantibodies,” Journal of Endocrinology & Metabolism 89(8):3702-3704, Aug. 2004.
Spencer, C.A., “Recoveries Cannot Be Used to Authenticate Thyroglobulin (Tg) Measurements When Sera Contain Tg Autoantibodies,” Clinical Chemistry 42(5):661-663, May 1996.
Spencer, C.A., et al., “Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients With Differentiated Thyroid Carcinoma,” Journal of Clinical Endocrinology and Metabolism 83(4):1121-1127, Apr. 1998.
Vali, M., et al., “Thyroglobulin as Autoantigen: Structure-Function Relationships,” Reviews in Endocrine & Metabolic Disorders 1(1-2):69-77, Jan. 2000.
Whitley, R.J., and K.B. Ain, “Thyroglobulin: A Specific Serum Marker for the Management of Thyroid Carcinoma,” Clinics in Laboratory Medicine 24(1):29-47, Mar. 2004.
Yang, S.-X., et al., “Glycosylation in Human Thyroglobulin: Location of the N-Linked Oligosaccharide Units and Comparison With Bovine Thyroglobulin,” Archives of Biochemistry and Biophysics 327(1):61-70, Mar. 1, 1996.
Zöphel, K., et al., “A Highly Sensitive Thyroglobulin Assay Has Superior Diagnostic Sensitivity for Recurrence of Differentiated Thyroid Cancer in Patients Undergoing TSH Suppression,” Journal of Nuclear Medicine 47(3):552-553, Mar. 2006.
Hoofnagle Andrew N.
Wener Mark
Christensen O'Connor Johnson & Kindness PLLC
Goddard Laura B
University of Washington
LandOfFree
Methods and compositions for detecting thyroglobulin in a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for detecting thyroglobulin in a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for detecting thyroglobulin in a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4186091